NIST logo

Publication Citation: Design and Use of a Peptide Nucleic Acid for Detection of the Heteroplasmic Low-Frequency Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes (MELAS) Mutation in Human Mitochondrial DNA

NIST Authors in Bold

Author(s): Diane K. Hancock; Frederick P. Schwarz; F H. Song; L J. Wong; Barbara C. Levin;
Title: Design and Use of a Peptide Nucleic Acid for Detection of the Heteroplasmic Low-Frequency Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes (MELAS) Mutation in Human Mitochondrial DNA
Published: December 01, 2002
Abstract: Most pathogenic human mitochondrial DNA (mtDNA) mutations are Heteroplasmic and are difficult to detect when present at very low levels in a population of normal mtDNA molecules. This paper describes a simple methodology to detect low levels of the single base pair Heteroplasmic MELAS (A3243G) mutation. A series of peptide nucleic acids (PNAs) was designed to bind to the wild type mtDNA, thus reducing the PCR amplification of the wild type mtDNA to background levels while permitting the mutant DNA to become the dominant product and readily discernable. This methodology will permit easy detection of the MELAS A3243G mutation is asymptomatic or symptomatic carriers with low to undetectable blood levels of this mutation.
Citation: Clinical Chemistry
Volume: 48
Issue: 12
Pages: pp. 2155 - 2163
Keywords: heteroplasmy;human;MELAS;mitochondrial DNA (mtDNA);peptide nucleic acid (PNA)
Research Areas: Life Sciences Research, Diagnostics